Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sigma-1 receptor (S1R), also known as sigma non-opioid intracellular receptor 1, is a unique ligand-operated chaperone protein primarily located at the endoplasmic reticulum (ER) membrane, especially in mitochondrial-associated membranes (MAMs). It modulates calcium signaling, lipid dynamics, and the cellular stress response by interacting with proteins such as GRP78/BiP and ion channels, GPCRs, kinases, and NMDA receptors. It has been implicated in neurological disorders, psychiatric conditions, drug dependence, cardiovascular function, and cancer.
Modulates calcium signaling, lipid dynamics, and cellular stress response through chaperone activity and interaction with various client proteins.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sigma receptor 1 (S1R).